
Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD.References https://pmc.ncbi.nlm.nih.gov/articles/PMC12314114/https://pmc.ncbi.nlm.nih.gov/articles/PMC12379780/https://pubmed.ncbi.nlm.nih.gov/31776871/https://pubmed.ncbi.nlm.nih.gov/40619095/https://pubmed.ncbi.nlm.nih.gov/28731336/https://pmc.ncbi.nlm.nih.gov/articles/PMC9426730/
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

GLP-1 Agonists (Ozempic, Wegovy) in Psychiatry

Landmark Studies: The STAR*D Trial

Dogs in Mental Health with Dr. Nancy Gee: A Biopsychosocial Approach

Landmark Studies: The CATIE Trial
Free AI-powered recaps of PsychRounds: The Psychiatry Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.